Table 3 Number and percentage of diabetic patients with abnormal baseline VEP findings, by study arm
From: Efficacy of ozone therapy on visual evoked potentials in diabetic patients
Parameter | Patient group | Number (%) |
|---|---|---|
P100 wave latency (ms) | Treatment arm | 14 (46.6) |
Control arm | 14 (46.6) | |
P100 amplitude (μV) | Treatment arm | 6 (20) |
Control arm | 5 (16.6) |